Reed Protects, Extends Special Diabetes Program
Tom Reed fought to secure an extension of the Special Diabetes Program included in the Protecting Access to Medicare Act of 2014 passed in the House Thursday. Reed, Vice Chair of the Congressional Diabetes Caucus, said the program has a track record of providing significant health benefits and demonstrates a strong return on investment for taxpayers.
“Working closely with our diabetes groups, we gained a victory today with a year-long extension of a program that has proven successful in delivering groundbreaking research in new treatment, technology and prevention services,” Reed said. “Saving this program means we have a better opportunity to advance diabetes research and prevention efforts.”
Reed has been working closely with diabetes organizations including the Juvenile Diabetes Research Foundation (JDRF) to ensure the Special Diabetes Program’s long-term viability.
"JDRF and its volunteers across the nation are working every day to create a world without type 1 diabetes (T1D)," said Jeffrey Brewer, JDRF's President and CEO. "We are so grateful for the support of the House of Representatives and Rep. Tom Reed for the renewal of Special Diabetes Program, which is critical to groundbreaking T1D research and provides tremendous return on investment for our nation and the millions of children and adults courageously fighting T1D every day."
“On behalf of all our New York employees, Novo Nordisk is grateful for Mr. Reed's leadership in helping deliver the renewal of the Special Diabetes Program -- great news and great hope for millions of American families living with diabetes,” said Christopher Porter, Chief Government Affairs Officer for Novo Nordisk.
Earlier this week Reed participated in the American Diabetes Association’s Alert Day to encourage support for the kinds of diabetes research supported by the Special Diabetes Program.
"The American Diabetes Association applauds the one-year renewal of the Special Diabetes Program. This program provides vital funding for diabetes research, prevention and treatment options among the American Indian population and for those living with type 1 diabetes," said Tekisha D. Everette, PhD, Managing Director, Federal Government Affairs, American Diabetes Association. "We thank Congressman Reed and his colleagues in the Congressional Diabetes Caucus for making diabetes a priority and for raising awareness and support for the Special Diabetes Program. The renewal of this program positively impacts the lives of millions of Americans living with this disease and is a step forward in our ongoing fight to stop diabetes."
Without passage of the “doc fix” access to programs like the Special Diabetes Program would be jeopardized and physicians would have suffered a 24 percent cut in Medicare reimbursement rates. Reed continues to push for a permanent fix that gives hospitals and patients long-term certainty.